Thus, we asked whether those genes that we found to be up-regulated in LS174T S2 and S11 cells were also up-regulated in patients showing high B4GALNT2 levels in cancer tissues and vice versa for genes displaying down-regulation in S2/S11 cells. This evidence concerns the gene B4GALNT2 and cancer.